Fig. 1From: The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s diseaseUpregulation of KCa3.1 channels and Iba1 in the brains of PD mouse model. a Western blot analysis of SNpc lysates from control and MPTP-induced PD mouse model analyzed by antibodies to TH, GFAP, Iba1, and KCa3.1. Data represent the mean ± SEM (n = 3). Western blot was repeated three times and showed similar results; *p < 0.05, unpaired, two-tailed Student’s t test compared with control. b Double immunofluorescence analysis of KCa3.1 (green) levels in microglia (Iba1, red) of control and MPTP group mouse SNpc. DAPI (blue) was used to label nuclei. Scale bar 50 μmBack to article page